PredxBio is a computational pathology company developing AI tools to analyze whole slide image pathology samples based on spatial analytics.
PredxBio has raised $601K in total funding. The most recent round was Seed. The last funding was announced in August 2023.
PredxBio's investors include Innovation Works, Keiretsu Forum, K4 Forum Mumbai Network.
PredxBio is headquartered in Pittsburgh, United States.
PredxBio is a computational pathology company developing AI tools to analyze whole slide image pathology samples based on spatial analytics.
PredxBio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PredxBio — Funding & Investors." VCBacked, August 17, 2023, https://www.vcbacked.co/company/predxbio. Accessed September 14, 2026.
VCBacked. (2023). PredxBio — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/predxbio
{{cite web |title=PredxBio — Funding & Investors |url=https://www.vcbacked.co/company/predxbio |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated